Prevalence and Risk Factors for Functional Vitamin B12 Deficiency in Patients with Crohn's Disease

被引:47
作者
Ward, Mark G. [1 ]
Kariyawasam, Viraj C. [1 ]
Mogan, Sathis B. [1 ]
Patel, Kamal V. [1 ]
Pantelidou, Maria [1 ]
Sobczynska-Malefora, Agata [2 ]
Porte, Francois [3 ]
Griffin, Nyree [3 ]
Anderson, Simon H. C. [1 ]
Sanderson, Jeremy D. [1 ,4 ]
Harrington, Dominic J. [2 ]
Irving, Peter M. [1 ,4 ]
机构
[1] Guys & St Thomas Hosp NHS Fdn Trust, Dept Gastroenterol, London, England
[2] St Thomas Hosp, Nutristasis Unit, Viapath, London SE1 7EH, England
[3] Guys & St Thomas Hosp NHS Fdn Trust, Dept Radiol, London, England
[4] Kings Coll London, Sch Med, Diabet & Nutr Sci Div, London WC2R 2LS, England
关键词
B12; deficiency; holoTC; Crohn's disease; imaging; INFLAMMATORY-BOWEL-DISEASE; METHYLMALONIC ACID; COBALAMIN DEFICIENCY; PLASMA HOMOCYSTEINE; ULCERATIVE-COLITIS; HOLOTRANSCOBALAMIN; DIAGNOSIS; MANAGEMENT; ANEMIA; ANASTOMOSIS;
D O I
10.1097/MIB.0000000000000559
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background:Crohn's disease (CD) is a risk factor for vitamin B-12 deficiency due to frequent involvement of the terminal ileum. Conventional screening for B-12 deficiency with serum B-12 is relatively insensitive and measures total B-12 concentration, of which a minority is present in a biologically active form. Holotranscobalamin (holoTC) combined with methylmalonic acid (MMA) is believed to be more accurate in identifying impaired B-12 status. We evaluated the prevalence and risk factors for B-12 deficiency using holoTC supported by MMA among patients with CD.Methods:We performed a single-center service evaluation of 381 patients with CD who underwent B-12 assessment (holoTC/MMA) and compared them with 141 patients with ulcerative colitis. Eighty-nine patients with CD underwent paired serum B-12 and holoTC. Among patients with CD, risk factors including terminal ileal resection length, ileal inflammation on endoscopy, and disease characteristics on magnetic resonance imaging were recorded.Results:Prevalence of B-12 deficiency among patients with CD was 33% compared with 16% in ulcerative colitis (P < 0.0001). In 89 patients who underwent paired tests, conventional testing identified B-12 deficiency in 5% of patients with CD, which increased to 32% using holoTC/MMA. Independent risk factors for B-12 deficiency were ileal resection length 20 cm (odds ratio: 3.0, 95% confidence interval, 1.5-6.0, P = 0.002) and >20 cm (odds ratio: 6.7, 95% confidence interval, 3.0-14.7, P < 0.0001) and ileal inflammation (odds ratio: 3.9, 95% confidence interval, 2.2-6.9, P < 0.0001). On magnetic resonance imaging, active terminal ileal inflammation (P = 0.02) and an increased disease burden (1 skip lesion, P = 0.01 and prestenotic dilatation >3 cm, P = 0.01) were associated with B-12 deficiency.Conclusions:Vitamin B-12 deficiency is common in patients with CD. holoTC supported by MMA identifies patients with B-12 deficiency considered replete on conventional testing.
引用
收藏
页码:2839 / 2847
页数:9
相关论文
共 54 条
  • [1] DIAGNOSIS OF COBALAMIN DEFICIENCY .1. USEFULNESS OF SERUM METHYLMALONIC ACID AND TOTAL HOMOCYSTEINE CONCENTRATIONS
    ALLEN, RH
    STABLER, SP
    SAVAGE, DG
    LINDENBAUM, J
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1990, 34 (02) : 90 - 98
  • [2] Optimal management of pernicious anemia
    Andres, Emmanuel
    Serraj, Khalid
    [J]. JOURNAL OF BLOOD MEDICINE, 2012, 3 : 97 - 103
  • [3] Vitamin B12 Deficiency in Inflammatory Bowel Disease: Prevalence, Risk Factors, Evaluation, and Management
    Battat, Robert
    Kopylov, Uri
    Szilagyi, Andrew
    Saxena, Anjali
    Rosenblatt, David S.
    Warner, Margaret
    Bessissow, Talat
    Seidman, Ernest
    Bitton, Alain
    [J]. INFLAMMATORY BOWEL DISEASES, 2014, 20 (06) : 1120 - 1128
  • [4] BEHREND C, 1995, EUR J GASTROEN HEPAT, V7, P397
  • [5] Hospitalisations and surgery in Crohn's disease
    Bernstein, Charles N.
    Loftus, Edward V., Jr.
    Ng, Siew C.
    Lakatos, Peter L.
    Moum, Bjorn
    [J]. GUT, 2012, 61 (04) : 622 - 629
  • [6] World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010
    Bernstein, Charles N.
    Fried, Michael
    Krabshuis, J. H.
    Cohen, Henry
    Eliakim, R.
    Fedail, Suleiman
    Gearry, Richard
    Goh, K. L.
    Hamid, Saheed
    Khan, Aamir Ghafor
    LeMair, A. W.
    Prof Malfertheiner
    Qin Ouyang
    Rey, J. F.
    Sood, Ajit
    Steinwurz, Flavio
    Thomsen, Ole O.
    Thomson, Alan
    Watermeyer, Gillian
    [J]. INFLAMMATORY BOWEL DISEASES, 2010, 16 (01) : 112 - 124
  • [7] Active B12: A rapid, automated assay for holotranscobalamin on the Abbott AxSYM analyzer
    Brady, Jeff
    Wilson, Lesley
    McGregor, Lynda
    Valente, Edward
    Orning, Lars
    [J]. CLINICAL CHEMISTRY, 2008, 54 (03) : 567 - 573
  • [8] SUBTLE AND ATYPICAL COBALAMIN DEFICIENCY STATES
    CARMEL, R
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1990, 34 (02) : 108 - 114
  • [9] Holotranscobalamin: Not Ready for Prime Time
    Carmel, Ralph
    [J]. CLINICAL CHEMISTRY, 2012, 58 (03) : 643 - 645
  • [10] Biomarkers of cobalamin (vitamin B-12) status in the epidemiologic setting: a critical overview of context, applications, and performance characteristics of cobalamin, methylmalonic acid, and holotranscobalamin II
    Carmel, Ralph
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2011, 94 (01)